Alexis de Rosnay will serve as chairperson of the Audit Committee, as well as serve on the Compensation Committee.
Alexis de Rosnay has 30 years of experience in Investment Banking, of which 19 in Healthcare. He was a CEO of a mid-sized financial institution, and an adviser in the Life Sciences space.
Most recently, Alexis was CEO of Canaccord Genuity Ltd, responsible for Capital Markets and Wealth Management in Europe. He was also Senior Executive Vice President, Canaccord Genuity Group Inc. and Global Head of Investment Banking.
Alexis started his work experience in Mergers & Acquisitions at Rothschild in 1990. He spent most of his career (since 1994) focusing on Life Sciences transactions (primarily at JP Morgan, Lehman Brothers, Lazard), be it mergers, acquisitions, divestitures, IPOs, or private placings.
Alexis is currently a Senior Adviser at Oddo-BHF, a leading Franco-German financial institution.